| Line item | 2025-12-31 FY | 2024-12-31 FY | 2023-12-31 FY | 2022-12-31 FY | 2021-12-31 FY |
|---|---|---|---|---|---|
| Revenue | $129.00K | – | $31.54M | $82.84M | $253.84M |
| Cost of Revenue | – | – | $31.19M | $82.19M | $248.58M |
| Gross Profit | $129.00K | – | $342.00K | $646.00K | $5.26M |
| Operating Expenses | $31.72M | $19.14M | $21.33M | $48.59M | $187.87M |
| R&D | – | – | – | – | – |
| SG&A | $31.63M | $18.18M | $18.01M | $46.49M | $43.73M |
| Operating Income | -$31.59M | -$19.14M | -$20.98M | -$47.94M | -$182.61M |
| Interest Expense | – | – | $525.00K | $1.03M | $245.00K |
| Tax Expense | -$2.73M | -$931.00K | -$228.00K | $74.00K | -$729.00K |
| Net Income | -$53.91M | -$40.97M | -$53.56M | -$84.71M | -$196.58M |
| EPS (basic) | -24.2000 | -26.0500 | -2.3400 | -0.0004 | -1.7181 |
| EPS (diluted) | -24.2000 | -26.0500 | -2.3400 | -0.0004 | -1.7181 |
| Shares (diluted) | $2.23M | $1.57M | $22.88M | $200.17M | $114.42M |